These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Association, expression, pathobiology: is too much tau in PD a blueprint for genetic association? Singleton A; Morris H Neurology; 2008 Jul; 71(1):11-2. PubMed ID: 18591501 [No Abstract] [Full Text] [Related]
30. Phenotypic associations of tau and ApoE in Parkinson's disease. Papapetropoulos S; Farrer MJ; Stone JT; Milkovic NM; Ross OA; Calvo L; McQuorquodale D; Mash DC Neurosci Lett; 2007 Mar; 414(2):141-4. PubMed ID: 17204369 [TBL] [Abstract][Full Text] [Related]
31. Clinical features and disease haplotypes of individuals with the N279K tau gene mutation: a comparison of the pallidopontonigral degeneration kindred and a French family. Tsuboi Y; Uitti RJ; Delisle MB; Ferreira JJ; Brefel-Courbon C; Rascol O; Ghetti B; Murrell JR; Hutton M; Baker M; Wszolek ZK Arch Neurol; 2002 Jun; 59(6):943-50. PubMed ID: 12056930 [TBL] [Abstract][Full Text] [Related]
32. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism. Hauser MA; Li YJ; Xu H; Noureddine MA; Shao YS; Gullans SR; Scherzer CR; Jensen RV; McLaurin AC; Gibson JR; Scott BL; Jewett RM; Stenger JE; Schmechel DE; Hulette CM; Vance JM Arch Neurol; 2005 Jun; 62(6):917-21. PubMed ID: 15956162 [TBL] [Abstract][Full Text] [Related]
33. Tau gene mutations and their effects. Goedert M Mov Disord; 2005 Aug; 20 Suppl 12():S45-52. PubMed ID: 16092090 [TBL] [Abstract][Full Text] [Related]
34. Interaction of alpha-synuclein and tau genotypes in Parkinson's disease. Mamah CE; Lesnick TG; Lincoln SJ; Strain KJ; de Andrade M; Bower JH; Ahlskog JE; Rocca WA; Farrer MJ; Maraganore DM Ann Neurol; 2005 Mar; 57(3):439-43. PubMed ID: 15732111 [TBL] [Abstract][Full Text] [Related]
35. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445 [TBL] [Abstract][Full Text] [Related]
36. Effects on splicing and protein function of three mutations in codon N296 of tau in vitro. Grover A; DeTure M; Yen SH; Hutton M Neurosci Lett; 2002 Apr; 323(1):33-6. PubMed ID: 11911984 [TBL] [Abstract][Full Text] [Related]
37. Pupil diameter in darkness differentiates progressive supranuclear palsy (PSP) from other extrapyramidal syndromes. Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Globas C; Schöls L; Antoni S; Ferger D; Reichmann H; Wilhelm H; Berg D; Ziemssen T Mov Disord; 2007 Oct; 22(14):2123-6. PubMed ID: 17853484 [TBL] [Abstract][Full Text] [Related]
39. Microtubule-associated protein tau (MAPT) influences the risk of Parkinson's disease among Indians. Das G; Misra AK; Das SK; Ray K; Ray J Neurosci Lett; 2009 Aug; 460(1):16-20. PubMed ID: 19450659 [TBL] [Abstract][Full Text] [Related]
40. The tau A0 allele in Parkinson's disease. Golbe LI; Lazzarini AM; Spychala JR; Johnson WG; Stenroos ES; Mark MH; Sage JI Mov Disord; 2001 May; 16(3):442-7. PubMed ID: 11391737 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]